COPENHAGEN, July 24 France's BioAlliance Pharma
and Denmark's Topotarget, both producers of rare cancer
drugs, said they would list as one company called Onxeo on the
NASDAQ OMX Copenhagen exchange as of Aug. 1 following their
Trading in Topotarget's shares will cease on July
31, and trading of Onxeo in Copenhagen will begin the next day.
BioAlliance Pharma will change its name to Onxeo on the same day
on the Euronext Paris exchange, the companies said on Thursday.
BioAlliance Pharma announced the takeover deal in April,
saying Topotarget shareholders would receive two new BioAlliance
Pharma shares for every 27 Topotarget shares they owned.
(Reporting by Sabina Zawadzki)